ClinicalTrials.Veeva

Menu
S

South Coast Retina Center | Long Beach, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Aflibercept
EYP-1901
MK-8748
Ranibizumab
IONIS-FB-LRx
EYE201
Pemafibrate
Abicipar Pegol

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 14 total trials

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

Active, not recruiting
Wet Age Related Macular Degeneration
wAMD
Drug: Aflibercept (2.0 mg)
Drug: EYP-1901
Locations recently updated

Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD).Available standard (usual) treatments for NVAMD, s...

Enrolling
Choroidal Neovascularization
Age-Related Macular Degeneration
Drug: Tiespectus
Drug: Aflibercept

Researchers are looking for new ways to treat diabetic macular edema (DME). In this trial, researchers want to learn if a trial medicine called MK-87...

Enrolling
Macular Edema
Diabetic Retinopathy
Drug: Aflibercept
Drug: MK-8748

This study is researching aflibercept high dose (HD), referred to as "study drug", with an experimental dosing regimen. The study is focused on parti...

Active, not recruiting
Neovascular Age-Related Macular Degeneration
Diabetic Macular Edema
Drug: Aflibercept 8 mg

This study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have Geographic Atroph...

Enrolling
Age-related Macular Degeneration (AMD)
Geographic Atrophy (GA)
Drug: Placebo
Drug: Pozelimab

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

Active, not recruiting
Diabetic Macular Edema (DME)
Diabetic Macular Edema
Drug: Aflibercept (2.0 mg)
Drug: EYP-1901

Trial sponsors

E
Jaeb Center for Health Research logo
Regeneron Pharmaceuticals logo
Allergan logo
Bayer logo
E
H
Ionis Pharmaceuticals logo
Merck Sharp & Dohme (MSD) logo
Roche logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems